drugset / Trial / NCT06781957
Pharmacokinetics of FSH and hCG After a Single Subcutaneous Injection of Gonadotropins-IBSA
RandomizedCrossoverQuadruple-blindTreatment
Summary
The objectives of this study is to evaluate the PK and the dose-proportionality of FSH and HCG following a single dose of Gonadotropins-IBSA, administered subcutaneously.
Timeline
- Start
- 2024-09-15
- Primary completion
- 2026-01-13
- Completion
- 2026-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gonadotropins-IBSA | Unknown | 75 iu | Subcutaneous |
| Subject | Gonadotropins-IBSA | Unknown | 225 iu | Subcutaneous |
| Subject | Gonadotropins-IBSA | Unknown | 450 iu | Subcutaneous |